Vistide (cidofovir)

Company
Gilead

Approval Status
Approved March 1999

Treatment for
Infectious Diseases

Possible similar drugs
Vistide

Areas
Immune System

Vistide (cidofovir injection) 75 mg/mL has been approved for the treatment of cytomegalovirus (CMV) retinitis in patients with AIDS.

Vistide_565 Drug Information

The Vistide_565 drug information shown above is licensed from Thomson CenterWatch. The information provided here is for general educational purposes only and does not constitute medical or pharmaceutical advice which should be sought from qualified medical and pharmaceutical advisers.

Scroll to top